These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23098208)

  • 21. p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.
    Wendt MK; Smith JA; Schiemann WP
    J Biol Chem; 2009 Dec; 284(49):34145-56. PubMed ID: 19822523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells.
    Vultur A; Buettner R; Kowolik C; Liang W; Smith D; Boschelli F; Jove R
    Mol Cancer Ther; 2008 May; 7(5):1185-94. PubMed ID: 18483306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kif1c regulates osteoclastic bone resorption as a downstream molecule of p130Cas.
    Kobayakawa M; Matsubara T; Mizokami A; Hiura F; Takakura N; Kokabu S; Matsuda M; Yasuda H; Nakamura I; Takei Y; Honda H; Hosokawa R; Jimi E
    Cell Biochem Funct; 2020 Apr; 38(3):300-308. PubMed ID: 31887784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells.
    Stewart TA; Azimi I; Brooks AJ; Thompson EW; Roberts-Thomson SJ; Monteith GR
    Int J Biochem Cell Biol; 2016 Jul; 76():64-74. PubMed ID: 27163529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
    Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
    Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal/stromal gene expression signature relates to basal-like breast cancers, identifies bone metastasis and predicts resistance to therapies.
    Marchini C; Montani M; Konstantinidou G; Orrù R; Mannucci S; Ramadori G; Gabrielli F; Baruzzi A; Berton G; Merigo F; Fin S; Iezzi M; Bisaro B; Sbarbati A; Zerani M; Galiè M; Amici A
    PLoS One; 2010 Nov; 5(11):e14131. PubMed ID: 21152434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
    Costamagna A; Rossi Sebastiano M; Natalini D; Simoni M; Valabrega G; Defilippi P; Visentin S; Ermondi G; Turco E; Caron G; Cabodi S
    Sci Rep; 2019 Feb; 9(1):3089. PubMed ID: 30816273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrin αβ1, αvβ, α6β effectors p130Cas, Src and talin regulate carcinoma invasion and chemoresistance.
    Sansing HA; Sarkeshik A; Yates JR; Patel V; Gutkind JS; Yamada KM; Berrier AL
    Biochem Biophys Res Commun; 2011 Mar; 406(2):171-6. PubMed ID: 21291860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology.
    Near RI; Zhang Y; Makkinje A; Vanden Borre P; Lerner A
    J Cell Physiol; 2007 Sep; 212(3):655-65. PubMed ID: 17427198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.
    Sciortino M; Camacho-Leal MDP; Orso F; Grassi E; Costamagna A; Provero P; Tam W; Turco E; Defilippi P; Taverna D; Cabodi S
    Sci Rep; 2017 Apr; 7(1):1145. PubMed ID: 28442738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal adhesion targeting of v-Crk is essential for FAK phosphorylation and cell migration in mouse embryo fibroblasts deficient src family kinases or p130CAS.
    Yeo MG; Sung BH; Oh HJ; Park ZY; Marcantonio EE; Song WK
    J Cell Physiol; 2008 Mar; 214(3):604-13. PubMed ID: 17786957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ezrin Is Associated with Disease Progression in Ovarian Carcinoma.
    Horwitz V; Davidson B; Stern D; Tropé CG; Tavor Re'em T; Reich R
    PLoS One; 2016; 11(9):e0162502. PubMed ID: 27622508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p130Cas controls the susceptibility of cancer cells to TGF-β-induced growth inhibition.
    Kang YS; Jeong DE; Lee EK; Song WK; Kim W
    Biochem Biophys Res Commun; 2013 Aug; 438(1):116-21. PubMed ID: 23872147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling.
    Schuh NR; Guerrero MS; Schrecengost RS; Bouton AH
    J Biol Chem; 2010 Jan; 285(4):2309-17. PubMed ID: 19940159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).
    Oliveras-Ferraros C; Corominas-Faja B; Cufí S; Vazquez-Martin A; Martin-Castillo B; Iglesias JM; López-Bonet E; Martin ÁG; Menendez JA
    Cell Cycle; 2012 Nov; 11(21):4020-32. PubMed ID: 22992620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P130Cas Src-binding and substrate domains have distinct roles in sustaining focal adhesion disassembly and promoting cell migration.
    Meenderink LM; Ryzhova LM; Donato DM; Gochberg DF; Kaverina I; Hanks SK
    PLoS One; 2010 Oct; 5(10):e13412. PubMed ID: 20976150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.
    Cursons J; Leuchowius KJ; Waltham M; Tomaskovic-Crook E; Foroutan M; Bracken CP; Redfern A; Crampin EJ; Street I; Davis MJ; Thompson EW
    Cell Commun Signal; 2015 May; 13():26. PubMed ID: 25975820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.